{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T03:34:19Z","timestamp":1758944059537},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6,20]]},"DOI":"10.4103\/0366-6999.207474","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T07:12:33Z","timestamp":1496387553000},"page":"1481-1490","source":"Crossref","is-referenced-by-count":2,"title":["E-26 Transformation-specific Related Gene Expression and Outcomes in Cytogenetically Normal Acute Myeloid Leukemia"],"prefix":"10.1097","volume":"130","author":[{"given":"Jian-Fei","family":"Fang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hai-Ning","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Fei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Bei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Liang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Ju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210129","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12288-014-0395-z","article-title":"The prognostic relevance of BAALC and ERG expression levels in cytogenetically normal pediatric acute myeloid leukemia","volume":"31","author":"Aref","year":"2015","journal-title":"Indian J Hematol Blood Transfus"},{"key":"R2-16-20210129","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0268-960X(03)00040-7","article-title":"Cytogenetics in acute leukemia","volume":"18","author":"Mr\u00f3zek","year":"2004","journal-title":"Blood Rev"},{"key":"R3-16-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1756-8722-2-23","article-title":"Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics","volume":"2","author":"Gregory","year":"2009","journal-title":"J Hematol Oncol"},{"key":"R4-16-20210129","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1182\/blood-2006-04-015826","article-title":"FLT3 tyrosine kinase domain mutations are biologically distinct from and have a significantly more favorable prognosis than FLT3 internal tandem duplications in patients with acute myeloid leukemia","volume":"110","author":"Mead","year":"2007","journal-title":"Blood"},{"key":"R5-16-20210129","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/leu.2016.343","article-title":"Diagnosis and relapse: Cytogenetically normal acute myelogenous leukemia without FLT3-ITD or MLL-PTD","volume":"31","author":"Chien","year":"2017","journal-title":"Leukemia"},{"key":"R7-16-20210129","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1182\/blood-2005-05-2164","article-title":"Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: Interaction with other gene mutations","volume":"106","author":"D\u00f6hner","year":"2005","journal-title":"Blood"},{"key":"R8-16-20210129","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1200\/JCO.2002.09.088","article-title":"Prognostic significance of partial tandem duplications of the MLL gene in adult patients 16 to 60 years old with acute myeloid leukemia and normal cytogenetics: A study of the Acute Myeloid Leukemia Study Group Ulm","volume":"20","author":"D\u00f6hner","year":"2002","journal-title":"J Clin Oncol"},{"key":"R9-16-20210129","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1200\/JCO.2008.20.5328","article-title":"ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: A comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays","volume":"27","author":"Metzeler","year":"2009","journal-title":"J Clin Oncol"},{"key":"R10-16-20210129","doi-asserted-by":"crossref","first-page":"4665","DOI":"10.1158\/0008-5472.CAN-09-0075","article-title":"ERG is a megakaryocytic oncogene","volume":"69","author":"Salek-Ardakani","year":"2009","journal-title":"Cancer Res"},{"key":"R11-16-20210129","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1182\/blood-2003-02-0359","article-title":"BAALC expression predicts clinical outcome of de novo acute myeloid leukemia patients with normal cytogenetics: A Cancer and Leukemia Group B Study","volume":"102","author":"Baldus","year":"2003","journal-title":"Blood"},{"key":"R12-16-20210129","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1038\/ng0294-146","article-title":"A second Ewing's sarcoma translocation, t (21;22), fuses the EWS gene to another ETS-family transcription factor, ERG","volume":"6","author":"Sorensen","year":"1994","journal-title":"Nat Genet"},{"key":"R14-16-20210129","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"R15-16-20210129","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/ni.1617","article-title":"The transcription factor Erg is essential for definitive hematopoiesis and the function of adult hematopoietic stem cells","volume":"9","author":"Loughran","year":"2008","journal-title":"Nat Immunol"},{"key":"R16-16-20210129","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1349-7006.2004.tb03320.x","article-title":"ETS transcription factors: Possible targets for cancer therapy","volume":"95","author":"Oikawa","year":"2004","journal-title":"Cancer Sci"},{"key":"R17-16-20210129","doi-asserted-by":"crossref","first-page":"5660","DOI":"10.1182\/blood-2010-06-290536","article-title":"BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B study","volume":"116","author":"Schwind","year":"2010","journal-title":"Blood"},{"key":"R18-16-20210129","doi-asserted-by":"crossref","first-page":"9234","DOI":"10.1200\/JCO.2005.03.6137","article-title":"Overexpression of the ETS-related gene, ERG, predicts a worse outcome in acute myeloid leukemia with normal karyotype: A Cancer and Leukemia Group B study","volume":"23","author":"Marcucci","year":"2005","journal-title":"J Clin Oncol"},{"key":"R19-16-20210129","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1200\/JCO.2007.10.8720","article-title":"High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: A Cancer and Leukemia Group B Study","volume":"25","author":"Marcucci","year":"2007","journal-title":"J Clin Oncol"},{"key":"R20-16-20210129","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1751-553X.2009.01168.x","article-title":"BAALC and ERG expression in acute myeloid leukemia with normal karyotype: Impact on prognosis","volume":"32","author":"Eid","year":"2010","journal-title":"Int J Lab Hematol"},{"key":"R21-16-20210129","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"R22-16-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"R23-16-20210129","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"R24-16-20210129","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"R26-16-20210129","doi-asserted-by":"crossref","first-page":"3915","DOI":"10.1073\/pnas.0400272101","article-title":"Acute myeloid leukemia with complex karyotypes and abnormal chromosome 21: Amplification discloses overexpression of APP, ETS2, and ERG genes","volume":"101","author":"Baldus","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R27-16-20210129","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-1119(02)01156-3","article-title":"Molecular biology of the Ets family of transcription factors","volume":"303","author":"Oikawa","year":"2003","journal-title":"Gene"},{"key":"R28-16-20210129","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1182\/blood.V98.12.3332","article-title":"Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation","volume":"98","author":"McLaughlin","year":"2001","journal-title":"Blood"},{"key":"R29-16-20210129","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med"},{"key":"R30-16-20210129","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1038\/sj.leu.2401905","article-title":"Constitutive activation of FLT3 stimulates multiple intracellular signal transducers and results in transformation","volume":"14","author":"Tse","year":"2000","journal-title":"Leukemia"},{"key":"R31-16-20210129","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00432-016-2290-5","article-title":"Outcome of FLT3-ITD-positive acute myeloid leukemia: Impact of allogeneic stem cell transplantation and tyrosine kinase inhibitor treatment","volume":"143","author":"Fleischmann","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"R32-16-20210129","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1200\/JCO.2005.01.6253","article-title":"BAALC expression and FLT3 internal tandem duplication mutations in acute myeloid leukemia patients with normal cytogenetics: Prognostic implications","volume":"24","author":"Baldus","year":"2006","journal-title":"J Clin Oncol"},{"key":"R33-16-20210129","doi-asserted-by":"crossref","first-page":"5371","DOI":"10.1182\/blood-2007-11-124958","article-title":"High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: A Cancer and Leukemia Group B (CALGB) study","volume":"111","author":"Langer","year":"2008","journal-title":"Blood"}],"container-title":["Chinese Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.4103\/0366-6999.207474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T19:43:31Z","timestamp":1623959011000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00029330-201706200-00016"}},"subtitle":["A Meta-analysis"],"short-title":[],"issued":{"date-parts":[[2017,6,20]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.4103\/0366-6999.207474","relation":{},"ISSN":["0366-6999"],"issn-type":[{"value":"0366-6999","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6,20]]}}}